Nat West Group PLC Eli Lilly & CO Transaction History

Nat West Group PLC

$291 Million
Q2 2024

A detailed history of Nat West Group PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Nat West Group PLC holds 13,860 shares of LLY stock, worth $11.2 Million. This represents 4.32% of its overall portfolio holdings.

Number of Shares

13,860

Previous 13,834 0.19%

Holding current value

$11.2 Million

Previous $10.8 Million 16.6%

% of portfolio

4.32%

Previous 4.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $18,846 - $23,635	26 Added 0.19%	13,860 $12.5 Million
Q1 2024 Apr 19, 2024	SELL	$592.2 - $792.28 $693,466 - $927,759	-1,171 Reduced 7.8%	13,834 $10.8 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $1.23 Million - $1.44 Million	-2,333 Reduced 13.46%	15,005 $8.75 Million
Q3 2023 Oct 12, 2023	BUY	$434.7 - $599.3 $283,859 - $391,342	653 Added 3.91%	17,338 $9.31 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $67,692 - $90,513	193 Added 1.17%	16,685 $7.82 Million

Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $98,469 - $115,647	317 Added 1.96%	16,492 $5.66 Million
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $19,614 - $22,854	61 Added 0.38%	16,175 $0
Q3 2022 Oct 31, 2022	BUY	$296.48 - $337.87 $4.78 Million - $5.44 Million	16,114 New	16,114 $5.21 Million
Q1 2021 Apr 16, 2021	SELL	$164.32 - $212.72 $493,452 - $638,798	-3,003 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $382,639 - $506,323	-2,933 Reduced 49.41%	3,003 $508,000
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $100,405 - $120,836	-736 Reduced 11.03%	5,936 $975,000
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $87,620 - $108,449	736 Added 12.4%	6,672 $926,000
Q3 2019 Oct 24, 2019	SELL	$106.79 - $116.16 $80,092 - $87,120	-750 Reduced 11.22%	5,936 $664,000
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $157,875 - $184,281	1,425 Added 27.09%	6,686 $741,000
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $461,936 - $543,733	-4,150 Reduced 44.1%	5,261 $682,000
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $247,594 - $277,380	-2,338 Reduced 19.9%	9,411 $1.09 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $78,991 - $98,725	-920 Reduced 7.26%	11,749 $1.26 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $7,570 - $8,688	-100 Reduced 0.78%	12,669 $1.08 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $106,120 - $125,267	-1,430 Reduced 10.07%	12,769 $988,000
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $310,552 - $333,103	-3,790 Reduced 21.07%	14,199 $1.2 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $2.44 Million - $2.71 Million	-31,719 Reduced 63.81%	17,989 $1.54 Million
Q2 2017 Aug 14, 2017	BUY	N/A	49,708	49,708 $4.09 Million

Others Institutions Holding LLY

# of Institutions

3,771

Shares Held

737M

Call Options Held

7.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $765B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nat West Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Nat West Group PLC with notifications on news.

Account

Nat West Group PLC Eli Lilly & CO Transaction History